Bruno Jawan

Author PubWeight™ 56.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006 3.09
2 Difficult ventilation with a double-lumen endotracheal tube: an unusual manufacturing defect. Anesth Analg 2005 2.14
3 Living donor liver transplantation: the Asian perspective. Transplantation 2014 2.13
4 Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2010 1.67
5 Massive pulmonary embolism presented as sudden cardiac arrest in the immediate postoperative period after laparoscopic hysterectomy. J Clin Anesth 2003 1.42
6 Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg 2003 1.10
7 Characterization of liver enzymes on living related liver transplantation patients with acute rejection. Hepatogastroenterology 2005 0.98
8 Liver resection for benign liver tumors: indications and outcome. Am J Surg 2007 0.96
9 Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation. Eur J Clin Invest 2011 0.96
10 Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy. Liver Transpl 2006 0.95
11 Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation. Ann Transplant 2010 0.95
12 Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation. Clin Transplant 2010 0.95
13 Routine microsurgical biliary reconstruction decreases early anastomotic complications in living donor liver transplantation. Liver Transpl 2009 0.95
14 Evaluation of living liver donors. Transplantation 2003 0.95
15 Right lobe living donor liver transplantation-addressing the middle hepatic vein controversy. Ann Surg 2003 0.94
16 Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats. Acta Pharmacol Sin 2005 0.92
17 Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan. Transplantation 2008 0.91
18 Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002 0.91
19 The renal-sparing efficacy of basiliximab in adult living donor liver transplantation. Liver Transpl 2005 0.90
20 Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation. Acta Pharmacol Sin 2006 0.90
21 Improving hepatic and portal venous flows using tissue expander and Foley catheter in liver transplantation. Clin Transplant 2006 0.90
22 Acute coronary syndrome in cisatracurium-induced anaphylactic shock: Kounis syndrome. Acta Anaesthesiol Taiwan 2008 0.89
23 Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation. Hepatogastroenterology 2012 0.89
24 Experimental and clinical significance of antinuclear antibodies in liver transplantation. Transplantation 2007 0.88
25 Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice. Biochem Biophys Res Commun 2004 0.88
26 Impact of vaccine therapy using nuclear histone H1 on allograft survival in experimental organ transplantation. Transpl Immunol 2007 0.86
27 Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice. Biochem Biophys Res Commun 2005 0.85
28 Involvement of autoimmunity against nuclear histone H1 in liver transplantation tolerance. Transpl Immunol 2008 0.85
29 The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction. Mol Immunol 2005 0.85
30 Multislice computed tomography angiography in pediatric liver transplantation. Transplantation 2003 0.84
31 Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis. J Hepatol 2009 0.83
32 Preemptive analgesia installation during gynecologic laparoscopy: a randomized trial. J Minim Invasive Gynecol 2005 0.83
33 Protective effect of MDL28170 against thioacetamide-induced acute liver failure in mice. J Biomed Sci 2004 0.83
34 Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl 2007 0.82
35 Diarrhea in medical care workers with severe acute respiratory syndrome. J Clin Gastroenterol 2004 0.82
36 Major hepatectomy in children: approaching blood transfusion-free. World J Surg 2006 0.81
37 Living donor liver transplantation for biliary atresia. Chang Gung Med J 2007 0.80
38 Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. J Gene Med 2006 0.80
39 Donor graft outflow venoplasty in living donor liver transplantation. Liver Transpl 2006 0.79
40 Section 1. Image evaluation of fatty liver in living donor liver transplantation. Transplantation 2014 0.79
41 Maintenance of normothermia at operation room temperature of 24 degrees C in adult and pediatric patients undergoing liver transplantation. Transpl Int 2005 0.79
42 Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol 2005 0.79
43 Intra-operative management of low portal vein flow in pediatric living donor liver transplantation. Transpl Int 2012 0.78
44 Anesthetic management of a patient with Alagille's syndrome undergoing living donor liver transplantation without blood transfusion. Chang Gung Med J 2004 0.78
45 Hepatic pseudotumor in long-standing biliary atresia patients undergoing liver transplantation. Liver Transpl 2007 0.78
46 Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation. Clin Transplant 2004 0.78
47 Perforation of the right ventricle by a pulmonary artery catheter that continues to measure cardiac output and mixed venous saturation. J Clin Anesth 2005 0.78
48 Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance. J Gastroenterol Hepatol 2007 0.78
49 Predictive factors for pediatric patients requiring massive blood transfusion during living donor liver transplantation. Ann Transplant 2013 0.78
50 High concentration of magnolol induces hepatotoxicity under serum-reduced conditions. Phytomedicine 2009 0.77
51 Section 18. Professional framework for liver transplantation for overseas patients: traveling for living donor liver transplantation. Transplantation 2014 0.77
52 Outcomes of long storage times for cryopreserved vascular grafts in outflow reconstruction in living donor liver transplantation. Liver Transpl 2014 0.77
53 Solitary pulmonary nodule in the liver transplant candidate: importance of diagnosis and treatment. Liver Transpl 2010 0.77
54 3DCT angiography for detection of vascular complications in pediatric liver transplantation. Liver Transpl 2004 0.76
55 The immunological role of lipid transfer/metabolic proteins in liver transplantation tolerance. Transpl Immunol 2006 0.76
56 Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants. Transpl Immunol 2006 0.76
57 The method and accuracy of documentation of intraoperative fluids management in liver transplantation recipients. Ann Transplant 2011 0.76
58 Deceased-donor liver transplantation: 10 years' experience at Change Gung Memorial Hospital-Kaohsiung Medical Center. Chang Gung Med J 2005 0.76
59 Dextrose in the banked blood products does not seem to affect the blood glucose levels in patients undergoing liver transplantation. World J Gastroenterol 2005 0.75
60 Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release. Cytokine 2009 0.75
61 Predictive factors associated with re-exploration for hemostasis in living donor liver transplantation. Ann Transplant 2012 0.75
62 Atrial septal defect in end-stage liver disease children before and after liver transplantation. Surgery 2007 0.75
63 Systemic immune response after laparoscopic and open cholecystectomy. World J Surg 2002 0.75
64 Angioplasty treatment of hepatic vein stenosis in pediatric liver transplants: long-term results. Transpl Int 2005 0.75
65 Use of a refined operative strategy in combination with the multidisciplinary approach to manage blunt juxtahepatic venous injuries. J Trauma 2005 0.75
66 Intraoperative blood and fluid administration differences in primary liver transplantation versus liver retransplantation. Acta Anaesthesiol Taiwan 2011 0.75
67 Modified protective suits for anesthesiologists performing tracheal intubation for severe acute respiratory syndrome patients in Taiwan. Anesthesiology 2004 0.75
68 Living donor liver transplantation in children with congenital heart disease. Transplantation 2007 0.75
69 Permanent loss of cervical spinal cord function after posterolateral fusion for lumbar spinal pyogenic spondylitis. Orthopedics 2008 0.75
70 Heat preconditioning ameliorates hepatocyte viability after cold preservation and rewarming, and modulates its immunoactivity. Transpl Immunol 2007 0.75
71 Section 8. Management of portal venous complications in pediatric living donor liver transplantation. Transplantation 2014 0.75
72 Two cases of massive pleural effusion noted only after induction of anesthesia in living donor liver transplantation. J Anesth 2011 0.75
73 The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells. Transpl Immunol 2007 0.75
74 Atropine-triggered idiopathic ventricular tachycardia in an asymptomatic pediatric patient. Can J Anaesth 2004 0.75